CatalYm

Tacalyx

This company develops antibody-based therapeutics targeting tumour associated carbohydrate antigens for the treatment of solid tumours in cancer patients.

Actym Therapeutics

This biotechnology company develops bacterial immunotherapies to treat solid tumours and fibrotic diseases for patients with advanced cancers.

BRENUS PHARMA

This company develops allogeneic cancer immunotherapies for patients with solid tumors using a proteomics-guided platform that mimics tumor cell resistance and escape mechanisms.

CellmAbs

This biotech company develops monoclonal antibodies and adoptive cell therapies to treat oncology patients with solid tumours.

Clinical stage immunotherapy company

This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.

Captain T Cell

The company develops cell therapies for cancer patients to treat solid tumours.

APIM Therapeutics AS

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses to treat patients with advanced solid tumours and multiple cancers.

PanCancerT

This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.